Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$5.07M Sell
27,451
-4,928
-15% -$872K 0.88% 36
2018
Q1
$5.52M Sell
32,379
-1,810
-5% -$332K 0.93% 36
2017
Q4
$5.95M Sell
34,189
-200
-0.6% -$35.4K 0.97% 38
2017
Q3
$6.41M Buy
34,389
+190
+0.6% +$33.7K 1.14% 30
2017
Q2
$5.89M Sell
34,199
-3,020
-8% -$491K 1.06% 32
2017
Q1
$6.11M Buy
37,219
+1,571
+4% +$261K 1.11% 30
2016
Q4
$5.21M Buy
35,648
+1,470
+4% +$221K 1.04% 32
2016
Q3
$5.7M Buy
34,178
+1,256
+4% +$212K 1.19% 29
2016
Q2
$5.01M Buy
32,922
+320
+1% +$49.8K 1.04% 33
2016
Q1
$4.89M Buy
32,602
+1,600
+5% +$238K 1.06% 33
2015
Q4
$5.03M Buy
31,002
+3,780
+14% +$594K 1.13% 32
2015
Q3
$3.77M Sell
27,222
-275
-1% -$43.3K 0.92% 36
2015
Q2
$4.22M Buy
27,497
+6,085
+28% +$975K 0.94% 38
2015
Q1
$3.42M Buy
21,412
+7,505
+54% +$1.18M 0.77% 42
2014
Q4
$2.21M Buy
13,907
+732
+6% +$114K 0.49% 52
2014
Q3
$1.85M Hold
13,175
0.42% 53
2014
Q2
$1.56M Buy
13,175
+3,525
+37% +$408K 0.35% 60
2014
Q1
$1.19M Buy
9,650
+3,750
+64% +$455K 0.28% 63
2013
Q4
$673K Buy
+5,900
New +$671K 0.16% 74

Other funds holding AMGN

Asset Advisors Corp's AMGN Position: Q2 2018 in Review

Asset Advisors Corp reduced its Amgen (AMGN) stake by 15% in Q2 2018, selling an estimated $872K and leaving 27,451 shares worth $5.07M. The position accounts for 0.88% of the portfolio, ranked #36.

Asset Advisors Corp first reported a position in AMGN in Q4 2013 and has held it in 19 quarters since. The position peaked at $6.41M in Q3 2017. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Asset Advisors Corp held 27,451 shares of Amgen worth $5.07M as of Q2 2018.
  • Asset Advisors Corp sold 4,928 Amgen shares in Q2 2018, an estimated $872K.
  • Amgen made up 0.88% of Asset Advisors Corp's portfolio in Q2 2018, its #36 holding.
  • Asset Advisors Corp first reported a position in Amgen in Q4 2013 and has held it in 19 quarters since.
  • Asset Advisors Corp's Amgen position peaked at $6.41M in Q3 2017.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Asset Advisors Corp's 13F filing for Q2 2018, filed 20 Jul 2018.